Skip to main content
. 2023 Oct 25;9(12):2409–2422. doi: 10.1021/acsinfecdis.3c00264

Figure 2.

Figure 2

Schematic pathway diagram showing the three stages of peptidoglycan biosynthesis (cytoplasmic precursor synthesis, membrane translocation, and polymerization and cross-linking) impacted by ceftazidime/avibactam treatment (48/4 mg/L) at 6 h. The diagram also shows the bar charts and table for the significantly impacted metabolites and genes involved in this metabolic pathway, respectively (log2FC ≥ 0.59 or ≤ −0.59, p < 0.05, false discovery rate (FDR) < 0.05).